GET THE APP
Andrea Borns, microbiologist and respiratory therapist who holds a Master’s of Public Health is the founder and Chief Executive Officer of ZEN Clinical and Bioscience. ZEN is a newly-formed consulting and laboratory client-driven research and development (R&D) company in the field of bacteriophage therapy and phage biotechnology to address emerging infectious and neglected tropical diseases. Originally from Brazil, Andrea started her career in Biomedical Sciences and was involved in HIV/AIDS research during the late ’90s in Rio de Janeiro. She is also a former Assistant Professor and Director of Clinical Education at the University of the District of Columbia, USA, where she worked closely with lung diseases, critical care, and mechanical ventilation before her comeback to the bench. Working on the bedside managing and treating cystic fibrosis and ventilator-associated pneumonia patients who lost their lives to superbugs, inspire her to leave Academia and the hospital environment to work in basic science. Andrea worked as a microbiologist at American Type Culture Collection (ATCC) and the Biodefense & Emerging Infection Resource (BEI), and as a research technician at the Walter Reed Army Institute of Research (WRAIR). Passionate about basic science, Andrea is interested in bringing the knowledge of phage biology from the bench to the bedside so it can benefit patients.
Henryk Kalisz obtained his PhD in Biochemistry at Manchester University and has published over 60 papers in reputed scientific journals. He has over 30 years of experience in industrial enzymology and biotechnology, including as Head of Biochemistry at Pharmacia Italy (Nerviano) and as Chief Scientific Officer at Eucodis Bioscience in Vienna, Austria. Since October 2011 he has been applying his expertise in industrial enzymology as a consultant and independent representative to provide scientific and technological advice and assistance to various Biotechnology and Pharmaceuticals organizations.
Fariha Altaaf is a young researcher in the field of Microbiology belongs to Pakistan. I have a passion and learn new expertise in evaluation in improving health and wellbeing. She is very passionate and hardworking to create new pathways for improving healthcare. She have done this research and built this model after years of experience in microbiology research, evaluation, teaching, and administration both from hospital and education institutions. The methodology in this research includes competitive ELISA that illustrates, seroprevalence and association of risk factors. It allows for value-pluralism. This research along with this methodology reveals the presence of BT virus that is transmitted from one region to another and still transmitting.